GOODRX HOLDINGS INC

NASDAQ: GDRX (GoodRx Holdings, Inc.)

Kemas kini terakhir: 17 Dec, 12:27PM

4.48

-0.12 (-2.51%)

Penutupan Terdahulu 4.59
Buka 4.64
Jumlah Dagangan 804,612
Purata Dagangan (3B) 1,325,130
Modal Pasaran 1,705,610,496
Harga / Pendapatan (P/E Ke hadapan) 13.40
Harga / Jualan (P/S) 2.42
Harga / Buku (P/B) 2.66
Julat 52 Minggu
4.09 (-8%) — 9.26 (106%)
Tarikh Pendapatan 26 Feb 2025 - 3 Mar 2025
Margin Keuntungan -2.05%
Margin Operasi (TTM) 10.48%
EPS Cair (TTM) -0.040
Pertumbuhan Hasil Suku Tahunan (YOY) 8.50%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -88.60%
Jumlah Hutang/Ekuiti (D/E MRQ) 78.19%
Nisbah Semasa (MRQ) 5.48
Aliran Tunai Operasi (OCF TTM) 155.02 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 88.56 M
Pulangan Atas Aset (ROA TTM) 4.21%
Pulangan Atas Ekuiti (ROE TTM) -2.06%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Health Information Services (US) Bercampur Menurun
Health Information Services (Global) Bercampur Menurun
Stok GoodRx Holdings, Inc. Menurun Menaik

AISkor Stockmoo

1.8
Konsensus Penganalisis 1.0
Aktiviti Orang Dalam NA
Volatiliti Harga 3.0
Purata Bergerak Teknikal 3.5
Osilator Teknikal -0.5
Purata 1.75

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
GDRX 2 B - - 2.66
TXG 2 B - - 2.25
OMCL 2 B - - 1.62
CERT 2 B - - 1.64
SDGR 2 B - - 3.20
MDRX 1 B - 11.06 0.870

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Sektor Healthcare
Industri Health Information Services
Gaya Pelaburan Small Core
% Dimiliki oleh Orang Dalam 11.90%
% Dimiliki oleh Institusi 70.75%

Pemilikan

Nama Tarikh Syer Dipegang
Francisco Partners Management, Lp 30 Sep 2024 70,078,184
Petrus Trust Company, Lta 30 Sep 2024 2,519,726
Rip Road Capital Partners Lp 30 Sep 2024 2,408,577
Technology Crossover Management X, Ltd. 30 Sep 2024 1,653,566
Julat 52 Minggu
4.09 (-8%) — 9.26 (106%)
Julat Harga Sasaran
6.00 (34%) — 7.00 (56%)
Tinggi 7.00 (Citigroup, 56.43%) Beli
Median 6.00 (34.08%)
Rendah 6.00 (Morgan Stanley, 34.08%) Pegang
6.00 (Barclays, 34.08%) Beli
Purata 6.33 (41.45%)
Jumlah 2 Beli, 1 Pegang
Harga Purata @ Panggilan 4.67
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Morgan Stanley 17 Dec 2024 6.00 (34.08%) Pegang 4.46
Citigroup 13 Nov 2024 7.00 (56.42%) Beli 4.66
Barclays 11 Nov 2024 6.00 (34.08%) Beli 4.89

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
18 Dec 2024 Pengumuman GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
17 Dec 2024 Pengumuman GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
16 Dec 2024 Pengumuman GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
09 Dec 2024 CNBC Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
05 Dec 2024 Pengumuman GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
13 Nov 2024 Pengumuman Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
07 Nov 2024 Pengumuman GoodRx Reports Third Quarter 2024 Results
04 Nov 2024 Pengumuman GoodRx to Participate in Upcoming Investor Conferences
31 Oct 2024 Pengumuman GoodRx Unveils New E-commerce Platform, Launches with Opill®
29 Oct 2024 Pengumuman GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
28 Oct 2024 Pengumuman Ronald E. Bruehlman Joins GoodRx Board of Directors
23 Oct 2024 Pengumuman GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
16 Oct 2024 Pengumuman GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
10 Oct 2024 Pengumuman GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2024 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda